Volume 11, Number 11—November 2005
Correction, Vol. 11, No. 8
In "Laboratory Exposures to Brucellae and Implications for Bioterrorism" by Pablo Yagupsky and Ellen Jo Baron, an error occurred in the dosage for rifampin prophylaxis. In the second sentence of the fourth paragraph under the heading "Postexposure Prophylaxis," the correct dosage of rifampin is 600 mg once daily.
The corrected text appears in the updated article at http://wwwnc.cdc.gov/eid/article/11/8/04-1197_article.htm.
We regret any confusion this error may have caused.
Suggested Citation: Correction, Vol. 11, No. 8. Emerg Infect Dis [serial on the Internet]. 2006, May [date cited]. http://dx.doi.org/10.3201/eid1111.C11111
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: February 17, 2012
- Page last updated: February 17, 2012
- Page last reviewed: February 17, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)